|View printer-friendly version|
|March 26, 2003 4:34 p.m.|
|Teva and Schering-Plough Enter into License Agreement Covering Schering-Plough's Ribavirin Patents|
Jerusalem, Israel, March 26, 2003 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that Teva Pharmaceuticals USA, Inc. has entered into a licensing agreement with Schering-Plough Corporation that will settle all patent litigation between the two companies regarding Schering-Plough's U.S. patents relating to ribavirin. No other products are involved. Financial terms of the agreement were not disclosed. The agreement is effective upon the court's dismissal of the relevant lawsuit.